Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Amrutanjan Health Care Q4 FY24 earnings call: Revenue & Margins | Arthneeti
Q4 FY24
OTC: ₹108.37 Cr, up 27.57% YoY (Q4 FY23: ₹84.95 Cr) . Key concall takeaways from Amrutanjan Health Care Ltd's Q4 FY24 earnings call — and how it ranks against…
24 Sept 2026
Amrutanjan Health Care Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
135.41 Cr, up 6.57% YoY (Q4 FY24: Rs. Key concall takeaways from Amrutanjan Health Care Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
24 Sept 2026
Amrutanjan Health Care Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
122.75 Cr, up 4.92% YoY (Q3 FY24: Rs. Key concall takeaways from Amrutanjan Health Care Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
24 Sept 2026
Amrutanjan Health Care Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
94.05 Cr, up 12.31% from Rs. Key concall takeaways from Amrutanjan Health Care Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.
24 Sept 2026
Amrutanjan Health Care Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
117.70 Cr, up 7.08% YoY (Page 22) . Key concall takeaways from Amrutanjan Health Care Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
24 Sept 2026
Amrutanjan Health Care Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
141.03 Cr, up 14.90% YoY (Q3 FY25: Rs. Key concall takeaways from Amrutanjan Health Care Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
24 Sept 2026
Amrutanjan Health Care Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
149.77 Cr, up 10.60% YoY (Q4 FY25: Rs. Key concall takeaways from Amrutanjan Health Care Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
24 Sept 2026
Amrutanjan Health Care Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
102.97 Cr, up 9.48% YoY (Rs. Key concall takeaways from Amrutanjan Health Care Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
24 Sept 2026
Hindware Home Innovation Q1 FY27: Capex ₹50 Cr | Arthneeti
Q1 FY27
Q1 FY27 Sales Volume for Pipes: 10,221 MT, ~28% YoY growth (Page 6) . Key concall takeaways from Hindware Home Innovation Ltd's Q1 FY27 earnings call — and how…
24 Sept 2026
Signpost India Q3 FY26: Revenue ₹142.3 Cr, PAT ₹18.1 Cr | Arthneeti
Q3 FY26
Quarterly Revenue (Q3FY26): ₹142.3 crore, up 27% YoY from ₹112.2 crore in Q3FY25 (Page 34). Key concall takeaways from Signpost India Ltd's Q3 FY26 earnings…
24 Sept 2026
Signpost India Q2 FY26: Revenue ₹134.02 Cr, PAT ₹15.70 Cr | Arthneeti
Q2 FY26
Q2FY26 revenue from operations was ₹134.02 crore, a 3% year-on-year increase from ₹129.70 crore in Q2FY25 (Page 34). Key concall takeaways from Signpost India…
24 Sept 2026
Bhageria Industries Q3 FY21: Revenue ₹113.6 Cr, PAT ₹22.5 Cr | Arthneeti
Q3 FY21
Q3FY21 Net Sales: Rs 113.6 crore, up 8.4% YoY from Rs 104.8 crore in Q3FY20. Key concall takeaways from Bhageria Industries Ltd's Q3 FY21 earnings call — and…
24 Sept 2026
Bhageria Industries Q4 FY21: Revenue ₹130 Cr, PAT ₹18 Cr | Arthneeti
Q4 FY21
Q4FY21 Net Sales: Rs 130 crore, up 29.3% YoY from Rs 101 crore in Q4FY20 (Page 4) . Key concall takeaways from Bhageria Industries Ltd's Q4 FY21 earnings call…
24 Sept 2026
Bhageria Industries Q1 FY22: Revenue ₹113.0 Cr, PAT ₹13.0 Cr | Arthneeti
Q1 FY22
Q1 FY22 Net Sales: Rs 113.0 crore, up 117.0% from Rs 52.1 crore in Q1 FY21 . Key concall takeaways from Bhageria Industries Ltd's Q1 FY22 earnings call — and…
24 Sept 2026
Bhageria Industries Q2 FY22: Revenue ₹141 Cr, PAT ₹15 Cr | Arthneeti
Q2 FY22
Q2 FY22 Net Sales: Rs 141 crore, up 33.7% YoY from Rs 106 crore in Q2 FY21 (Page 5). Key concall takeaways from Bhageria Industries Ltd's Q2 FY22 earnings call…
24 Sept 2026
Bhageria Industries Q1 FY19: Revenue ₹113.3 Cr, PAT ₹17.9 Cr | Arthneeti
Q1 FY19
Q1FY19 Revenue: Rs 113.3 Cr . Key concall takeaways from Bhageria Industries Ltd's Q1 FY19 earnings call — and how it ranks against sector peers.
24 Sept 2026
Bhageria Industries Q2 FY19: Revenue ₹121.6 Cr, PAT ₹28.2 Cr | Arthneeti
Q2 FY19
Q2FY19 net sales: Rs 121.6 Cr, up 35.4% from Rs 89.8 Cr in Q2FY18 (Page 10) . Key concall takeaways from Bhageria Industries Ltd's Q2 FY19 earnings call — and…
24 Sept 2026
Bhageria Industries Q3 FY19: Revenue ₹112.1 Cr, PAT ₹15.1 Cr | Arthneeti
Q3 FY19
Q3FY19 Revenue: Rs 112.1 Cr, up 23.7% YoY from Rs 90.6 Cr in Q3FY18 (Page 10). Key concall takeaways from Bhageria Industries Ltd's Q3 FY19 earnings call — and…
24 Sept 2026
Bhageria Industries Q4 FY19: Revenue ₹109.2 Cr, PAT ₹10.3 Cr | Arthneeti
Q4 FY19
Q4FY19 Net Sales: Rs 109.2 crore, up 4.7% from Rs 104.3 crore in Q4FY18 (Page 8). Key concall takeaways from Bhageria Industries Ltd's Q4 FY19 earnings call…
24 Sept 2026
Bhageria Industries Q2 FY20: Revenue ₹108.4 Cr, PAT ₹17.2 Cr | Arthneeti
Q2 FY20
Q2FY20 Net Sales: Rs 108.4 Cr, down 13.6% YoY (Q2FY19: Rs 125.5 Cr) . Key concall takeaways from Bhageria Industries Ltd's Q2 FY20 earnings call — and how it…
24 Sept 2026